## Abstract Dyskinesia, secondary to dopamine replacement therapy, is the major complication of currently available therapies for Parkinson's disease. Alpha~2~ adrenoceptor antagonists, such as idazoxan, can significantly reduce levodopa‐induced dyskinesia in the 1‐methyl‐4‐phenyl‐1,2,3,6‐tetrahydr
✦ LIBER ✦
Effects of an alpha-2 adrenoceptor antagonist, Org 3770, upon the autonomic function of the pupil
✍ Scribed by E. Palazidou; J. M. A. Sitsen; S. A. Checkley
- Publisher
- John Wiley and Sons
- Year
- 1990
- Tongue
- English
- Weight
- 326 KB
- Volume
- 5
- Category
- Article
- ISSN
- 0885-6222
No coin nor oath required. For personal study only.
✦ Synopsis
The effects of a single oral dose of an alpha-2 adrenoceptor antagonist, Org 3770 (30mg), upon the autonomic function of the human pupil have been investigated in six volunteers. Org 3770 reduced pupil diameter, possibly as a result of its alpha-2 adrenoceptor blocking activity. Org 3770 did not reduce the mydriatric effect of phenylephrine and tyramine, nor was the miotic response to pilocarpine affected. These results are consistent with a blockade by Org 3770 of central alpha-2 adrenoceptors.
📜 SIMILAR VOLUMES
Neural mechanisms underlying peak-dose d
✍
Susan H. Fox; Brian Henry; Micheal P. Hill; David Peggs; Alan R. Crossman; Jonat
📂
Article
📅
2001
🏛
John Wiley and Sons
🌐
English
⚖ 102 KB